Phase I Study of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Formulation in Patients With Advanced Cancer.
Phase of Trial: Phase I
Latest Information Update: 30 Apr 2014
At a glance
- Drugs Paclitaxel (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors INSYS Therapeutics, Inc
- 01 Jul 2011 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov record.
- 01 Jul 2011 Status changed from active, no longer recruiting to completed reported by ClinicalTrials.gov.
- 12 Apr 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.